Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution.

Vaia FlorouAndrew E RosenbergEric WiederKrishna V KomanduriDespina KoloniasMohamed UdumanJohn C CastleJennifer S BuellJonathan C TrentBreelyn A Wilky

Published in: Journal for immunotherapy of cancer (2019)

This case series underscores the value of targeted immunotherapy in treating angiosarcoma. It also identifies genetic heterogeneity of cutaneous angiosarcomas and discusses specific genetic findings that may explain reported benefits from immunotherapy.

Keyphrases

genome wide
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
dna methylation
gene expression
cancer therapy
single cell
patient reported outcomes
patient reported